Prediction system for bleeding risk after thrombolysis

Abstract

The invention relates to the field of medical diagnosis and especially to a prediction system for a bleeding risk after thrombolysis. The system comprises an access controller, a serum creatinine detection part, a first assigning module, a leucocyte counting part, a second assigning module, a sample information reception function module, a third assigning module, a risk calculation module and a main interface of a report system, the risk calculation module receives assignments of the first, second and third assigning modules, and calculates the bleeding risk after thrombolysis according to thetotal score of the assignments. The serum creatinine level is included in the risk detection range of the system, and the bleeding risk after thrombolysis treatment of a patient can be evaluated in amore comprehensive and customized way. According to the system, operation is simple, an evaluation result is displayed visually, and the bleeding risk after thrombolysis can be evaluated accurately and rapidly.

Description

technical field [0001] The invention relates to the field of medical diagnosis, in particular to a prediction system for bleeding risk after thrombolysis. Background technique [0002] At present, serological marker detection reagents or methods can be used for the rapid detection of bleeding risk after thrombolysis. A reagent for microbleeds in patients with cerebral infarction, which consists of reagents for detecting any one or more of adiponectin, E-selectin, S100B protein, and soluble advanced glycation end product receptor sRAGE, and is used to detect cerebral infarction The content of adiponectin, E-selectin, S100B and soluble advanced glycation end product receptors in the patient's venous blood, so as to early judge whether the patient may have microbleeds; or, for example, the publication number is CN105203749 A, and the publication date is The Chinese patent application dated December 30, 2015 discloses a serum marker for assessing the risk of cerebral hemorrhage...

AI Technical Summary

Problems solved by technology

[0003] However, the problem with the detection reagent or method is that it pays more attention to the risk of cerebral hemorrhage, and has no obvious detection significance for hemorrhage in other important organs except cerebral hemorrhage, and severe hemorrhage such as gastrointestinal bleeding after thrombolytic therapy may also Poor prognosis of patients, requiring active treatment measures such as blood transfusion, and may even be life-threatening; in addition, the above-mentioned methods are complicated and require special reagents / tools and methods, which are difficult to implement in the central and western regions where the economy is underdeveloped or there are relatively few hospitals with interventional treatment qualifications. regions, or primary and secondary medical institutions

The problems of this detection method include: the medical level varies greatly in different regions, and the relevant training received by doctors of different levels varies greatly. First, it is difficult to standardize the detection of hemorrhage after thrombolysis in order to control the follow-up treatment, resulting in patients who can undergo thrombolysis Patients with high risk of bleeding did not receive treatment due to concerns about the risk of bleeding, and patients with high bleeding risk experienced more serious complications after receiving thrombolysis. Clinical operations provide a reference, but it is still impossible to individually detect the bleeding risk of patients receiving thrombolytic therapy, and hematological markers that are increasingly valued clinically have not been included in the scope of risk detection

Images